The Rainwater Charitable Foundation Unveils 2025 Rainwater Prize Winners, Honoring Researchers' Dedication to Primary Tauopathies and Neurodegenerative Diseases
07.08.2025 - 18:08:39"I'm honored to join the group of talented researchers recognized by this award," said Dr. Frost. "This funding will allow us to broaden our scope regarding retrotransposon activation in tauopathy and devote more effort to developing potential treatments. It's an exciting time to study neurodegeneration, and this support will help us move faster and go further in our research."
For more information on the 2025 Rainwater Prize winners, please visit www.rainwaterprize.org.
About the Rainwater Charitable Foundation's Medical Research
The Rainwater Charitable Foundation (RCF) was created in the early 1990s by renowned private equity investor and philanthropist Richard E. Rainwater. When Richard was diagnosed with a rare neurodegenerative disease and primary tauopathy called Progressive Supranuclear Palsy (PSP), the RCF expanded its mission to accelerate the development of new diagnostics and treatments for tau-related neurodegenerative disorders. The RCF Medical Research Team support this focus by managing the Tau Consortium, the Rainwater Prize Program and the Tauopathy Challenge Workshop. With over $140 million invested in medical research to date, the RCF has helped to advance eight treatments into human trials. Currently the RCF supports a range of programs, including a focus on family economic security, medical research, and other initiatives that drive positive change. For more information, please visit rainwatercharitablefoundation.org.
Corporate Contact:
Jordan Brainerd
The Rainwater Charitable Foundation
jbrainerd@rainwatercf.org
(817) 820-2708
Media Contact:
Kerry Sinclair
Spectrum Science
ksinclair@spectrumscience.com
(310) 710-0321
View original content:
